Safety and effective of laparoscopic microwave ablation for giant hepatic hemangioma: A retrospective cohort study

Libo Chen; Lei Zhang; Min Tian; Qinggang Hu; Lei Zhao; Jun Xiong

doi:10.1016/j.amsu.2019.02.001

Safety and effective of laparoscopic microwave ablation for giant hepatic hemangioma: A retrospective cohort study

Ann Med Surg (Lond). 2019 Feb 5:39:29-35. doi: 10.1016/j.amsu.2019.02.001. eCollection 2019 Mar.

Authors

Libo Chen¹, Lei Zhang¹, Min Tian², Qinggang Hu², Lei Zhao³, Jun Xiong²

Affiliations

¹ Department of Emergency Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, 430022, China.
² Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, 430022, China.
³ Department of Infectious Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, 430022, China.

Abstract

Introduction: The purpose of this study was to evaluate the advantages and disadvantages of laparoscopic microwave ablation (LMWA) as compared with conventional open resection (ORES) for the treatment of giant hepatic hemangioma.

Methods: and analysis: A retrospective chart review was conduct on patients with hepatic hemangioma underwent LMWA or ORES between 2014 and 2016.

Results: Of 131 patients, 37 patients underwent ORES and 94 patients underwent LMWA. Blood loss, operative time, postoperative hospital stay, hospital cost (RMB) were significantly different between two groups. Patients after LMWA experienced significantly less pain than those patients undergoing ORES. At a mean follow-up period of 12.8 ± 3.6 months in ORES group and 13.5 ± 2.5 months in LMWA group, no long-term complication was observed.

Conclusion: Compared with ORES, LMWA is a safe and effective minimally invasive for treating giant hepatic hemangioma.

Keywords: Ablation techniques; Hemangioma; Laparoscopes; Liver.